These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31509621)

  • 1. Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging.
    Vemuri P; Lesnick TG; Knopman DS; Przybelski SA; Reid RI; Mielke MM; Graff-Radford J; Lowe VJ; Machulda MM; Petersen RC; Jack CR
    Ann Neurol; 2019 Dec; 86(6):866-877. PubMed ID: 31509621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
    Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
    Baran TM; Lin FV;
    J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locus coeruleus integrity and left frontoparietal connectivity provide resilience against attentional decline in preclinical alzheimer's disease.
    Pahl J; Prokopiou PC; Bueichekú E; Schultz AP; Papp KV; Farrell ME; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
    Alzheimers Res Ther; 2024 May; 16(1):119. PubMed ID: 38822365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.
    Vemuri P; Lesnick TG; Przybelski SA; Graff-Radford J; Reid RI; Lowe VJ; Zuk SM; Senjem ML; Schwarz CG; Gunter JL; Kantarci K; Machulda MM; Mielke MM; Petersen RC; Knopman DS; Jack CR
    Ann Neurol; 2018 Nov; 84(5):705-716. PubMed ID: 30264411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
    Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
    Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When functional blurring becomes deleterious: Reduced system segregation is associated with less white matter integrity and cognitive decline in aging.
    Pedersen R; Geerligs L; Andersson M; Gorbach T; Avelar-Pereira B; Wåhlin A; Rieckmann A; Nyberg L; Salami A
    Neuroimage; 2021 Nov; 242():118449. PubMed ID: 34358662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
    Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
    Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.
    Rabin JS; Pruzin J; Scott M; Yang HS; Hampton O; Hsieh S; Schultz AP; Buckley RF; Hedden T; Rentz D; Johnson KA; Sperling RA; Chhatwal JP
    Neurology; 2022 Jul; 99(3):e270-e280. PubMed ID: 35473760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
    Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
    AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
    Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
    J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
    Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
    J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
    Vassilaki M; Crowson CS; Davis Iii JM; Duong SQ; Jones DT; Nguyen A; Mielke MM; Vemuri P; Myasoedova E
    J Alzheimers Dis; 2022; 89(3):943-954. PubMed ID: 35964191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint associations of β-amyloidosis and cortical thickness with cognition.
    Knopman DS; Lundt ES; Therneau TM; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC; Jack CR
    Neurobiol Aging; 2018 May; 65():121-131. PubMed ID: 29471214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of cognitive impairment in cerebral amyloid angiopathy.
    Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
    Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathy.
    Schipper MR; Vlegels N; van Harten TW; Rasing I; Koemans EA; Voigt S; Luca A; Kaushik K; van Etten ES; van Zwet EW; Terwindt GM; Biessels GJ; van Osch MJ; van Walderveen MA; Wermer MJ
    J Cereb Blood Flow Metab; 2023 Dec; 43(12):2144-2155. PubMed ID: 37708241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shades of white: diffusion properties of T1- and FLAIR-defined white matter signal abnormalities differ in stages from cognitively normal to dementia.
    Riphagen JM; Gronenschild EHBM; Salat DH; Freeze WM; Ivanov D; Clerx L; Verhey FRJ; Aalten P; Jacobs HIL
    Neurobiol Aging; 2018 Aug; 68():48-58. PubMed ID: 29704648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in sporadic cerebral amyloid angiopathy.
    Charidimou A; Boulouis G; Gurol ME; Ayata C; Bacskai BJ; Frosch MP; Viswanathan A; Greenberg SM
    Brain; 2017 Jul; 140(7):1829-1850. PubMed ID: 28334869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.